NextGen Healthcare (NXGN) Stock Price
NextGen Healthcare Price
Revenue has compounded at 12.4% per year over the past 19 years to 653.17 M USD. Earnings per share have declined at 11.1% per year over the last 18 years. NextGen Healthcare's net margin stands at -0.4%, down from 4.6% several years earlier. The payout ratio is around 174% of earnings.
NextGen Healthcare stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of NextGen Healthcare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how NextGen Healthcare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing NextGen Healthcare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | NextGen Healthcare Price |
|---|
NextGen Healthcare Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
NextGen Healthcare Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.49 | 0.49 | 0.51 | 0.53 | 0.53 | 0.54 | 0.56 | 0.60 | 0.65 | 0.73 | 0.79 | 0.84 | 0.90 | 0.96 | 1.02 | 1.17 |
| 10.36 | 0.41 | 3.46 | 4.32 | -0.38 | 2.08 | 2.96 | 7.19 | 9.56 | 12.10 | 7.24 | 6.88 | 6.67 | 6.93 | 7.00 | 14.65 |
| 54.49 | 54.07 | 56.19 | 54.43 | 53.31 | 50.37 | 50.54 | 50.34 | 47.63 | 47.63 | 47.63 | 47.63 | 47.63 | 47.63 | 47.63 | 47.63 |
| 267.00 | 266.00 | 286.00 | 289.00 | 282.00 | 272.00 | 281.00 | 300.00 | 311.00 | 348.62 | 373.87 | 399.58 | 426.26 | 455.78 | 487.69 | 559.13 |
| 36.00 | 39.00 | 34.00 | 7.00 | 32.00 | 20.00 | 20.00 | 11.00 | 1.00 | 100.00 | 120.00 | 142.00 | 164.00 | 183.00 | 215.00 | 242.00 |
| 7.35 | 7.93 | 6.68 | 1.32 | 6.05 | 3.70 | 3.60 | 1.85 | 0.15 | 13.66 | 15.29 | 16.92 | 18.32 | 19.12 | 21.00 | 20.61 |
| 27.00 | 5.00 | 18.00 | 2.00 | 24.00 | 7.00 | 9.00 | 1.00 | -2.00 | 75.00 | 91.00 | 105.00 | 129.00 | 144.00 | 161.00 | 204.00 |
| 80.00 | -81.48 | 260.00 | -88.89 | 1,100.00 | -70.83 | 28.57 | -88.89 | -300.00 | -3,850.00 | 21.33 | 15.38 | 22.86 | 11.63 | 11.81 | 26.71 |
| 60.80 | 61.20 | 62.00 | 63.40 | 64.60 | 65.60 | 66.90 | 67.79 | 67.01 | 67.01 | 67.01 | 67.01 | 67.01 | 67.01 | 67.01 | 67.01 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales NextGen Healthcare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue NextGen Healthcare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare NextGen Healthcare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares NextGen Healthcare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against NextGen Healthcare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
NextGen Healthcare stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
NextGen Healthcare Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
NextGen Healthcare business model & stock analysis
NextGen Healthcare SWOT Analysis
Strengths
NextGen Healthcare Inc possesses several strengths that contribute to its competitive advantage and market position:
- Strong brand reputation and recognition in the healthcare industry
- Extensive portfolio of innovative healthcare software solutions
- Robust and scalable platform that enables efficient data management
- Established customer base with long-term contracts
- Strong financial performance and ability to invest in research and development
Weaknesses
While NextGen Healthcare Inc is a market leader, it also faces certain weaknesses that it needs to address:
- Dependence on third-party vendors for certain components of its software solutions
- Relatively high product implementation and maintenance costs
- Integration challenges with legacy systems of healthcare providers
- Limited international market presence compared to domestic competitors
- Potential legal and regulatory risks in the healthcare industry
Opportunities
NextGen Healthcare Inc can leverage the following opportunities to drive growth and expansion:
- Increasing demand for electronic health records (EHR) systems and healthcare IT solutions
- Emerging markets and potential for international expansion
- Partnerships and collaborations with healthcare providers to develop customized solutions
- Advancements in healthcare technology, such as telehealth and artificial intelligence
- Growing focus on population health management and value-based care
Threats
NextGen Healthcare Inc should be vigilant of the following threats that may impact its business:
- Intense competition from other established healthcare IT vendors
- Changing regulatory landscape and compliance requirements
- Rapid technological advancements that may disrupt existing healthcare IT solutions
- Data security risks and potential breaches compromising patient privacy
- Budget constraints in the healthcare industry affecting IT spending
NextGen Healthcare Segments
NextGen Healthcare Revenue by Segment (1/2)
3 Years
5 Years
Max
Details
NextGen Healthcare Revenue by Segment (2/2)
3 Years
Max
Details
NextGen Healthcare Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
NextGen Healthcare historical P/E ratio, EBIT multiple, and P/S ratio
NextGen Healthcare annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
NextGen Healthcare shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
NextGen Healthcare stock splits
NextGen Healthcare Dividend History
12 years of dividend payments
NextGen Healthcare dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
NextGen Healthcare Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/14/2024 | 0.30USD | 189.39 MUSD | 2024 Q4 |
| 1/22/2024 | 0.28USD | 182.03 MUSD | 2024 Q3 |
| 7/24/2023 | 0.24USD | 165.84 MUSD | 2024 Q1 |
| 5/15/2023 | 0.29USD | 164.97 MUSD | 2023 Q4 |
| 1/23/2023 | 0.28USD | 163.05 MUSD | 2023 Q3 |
| 10/25/2022 | 0.23USD | 158.03 MUSD | 2023 Q2 |
| 7/26/2022 | 0.16USD | 155.20 MUSD | 2023 Q1 |
| 5/17/2022 | 0.20USD | 152.32 MUSD | 2022 Q4 |
| 1/25/2022 | 0.21USD | 148.51 MUSD | 2022 Q3 |
| 10/28/2021 | 0.23USD | 145.54 MUSD | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the NextGen Healthcare stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
NextGen Healthcare shareholder structure
| % | Name |
|---|---|
14.75983% | |
12.27523% | |
10.41224% | |
3.75243% | |
3.06515% | |
2.93159% |
NextGen Healthcare Executives and Management Board
Mr. David Sides
(53)President, Chief Executive Officer, Director · since 2021
Mr. James Arnold
(67)Chief Financial Officer, Executive Vice President
Mr. Srinivas Velamoor
(48)Executive Vice President, Chief Growth and Strategy Officer
Mr. Mitchell Waters
(59)Executive Vice President - Commercial Growth
Mr. Jeffrey Linton
(60)Executive Vice President, General Counsel, Secretary
NextGen Healthcare Supply Chain
NextGen Healthcare Supply Chain
Correlation: how closely stock prices move together
| # | Name | 1M | 3M | 6M | 1Y | 2Y | Trend |
|---|---|---|---|---|---|---|---|
| 1 | 0.21 | 0.48 | -0.60 | -0.74 | 0.40 | ||
| 2 | 0.54 | 0.67 | -0.40 | -0.75 | 0.37 | ||
| 3 | ReWalk Robotics Ltd | 0.59 | 0.80 | -0.38 | -0.60 | 0.31 | |
| 4 | 0.11 | 0.60 | -0.59 | 0.07 | 0.30 |
| # | Name | 1M | 3M | 6M | 1Y | 2Y | Trend |
|---|---|---|---|---|---|---|---|
| 1 | -0.36 | -0.15 | 0.62 | 0.82 | — | ||
| 2 | 0.40 | 0.69 | -0.47 | — | — | ||
| 3 | -0.48 | -0.14 | 0.79 | 0.84 | — | ||
| 4 | 0.61 | 0.72 | -0.35 | -0.53 | -0.04 | ||
| 5 | 0.28 | 0.66 | -0.58 | -0.85 | 0.07 |
Frequently asked questions about NextGen Healthcare
NextGen Healthcare Inc. operates as a provider of healthcare information technology (IT) solutions. The company's business model revolves around developing and implementing software and services that help healthcare organizations manage and optimize their clinical, financial, and administrative operations. NextGen Healthcare Inc. offers a range of products and solutions, including electronic health records (EHR), practice management systems, revenue cycle management solutions, population health management tools, and patient engagement platforms. By offering comprehensive and innovative IT solutions tailored for the healthcare industry, NextGen Healthcare Inc. aims to improve patient care and provider efficiency while increasing revenue for healthcare organizations.
NextGen Healthcare stock
NextGen Healthcare Peer Group
NextGen Healthcare Ticker
NextGen Healthcare FIGI
All fundamentals and in-depth analysis of NextGen Healthcare
Our stock analysis for NextGen Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NextGen Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.